A third global biosimilars week awareness campaign running from 14-18 November has been launched by the International Generic and Biosimilar Medicines Association, with the IGBA also taking this opportunity to launch a new white paper that urges the uptake of recommendations from the World Health Organization’s latest revised biosimilars guideline from earlier this year.
“In the week ahead, IGBA will renew its commitment to the collaborative effort to establish worldwide biosimilar policies that deliver...






